Table 3 Clinical follow-up of patients of DDD and C3GN
From: Clinico-pathologic spectrum of C3 glomerulopathy-an Indian experience
| Â | DDD n (%) TOTAL 13 cases | C3GN n (%) TOTAL 14 cases |
|---|---|---|
Nephrotic syndrome | 7/13 (53.9%) | 4/14 (28.6%) |
| Â | No CR/PR | 1 (9.05%) achieved CR |
| Â | 7 (100%)-SRNS | 2 (18.1%) achieved PR |
| Â | Â | 1 (25%) SRNS |
Nephrotic-nephritic presentation | 2/13 (15.4%) | 8 (57.1%) |
| Â | No CR/PR | No CR/PR |
| Â | No Progression to ESRD | No Progression to ESRD |
Advanced renal failure | 4/13 (30.8%) | 2 (14.3%) |
| Â | No CR/PR | 1 (50%)-Complete remission |
| Â | 4 (100%)-Progression to ESRD | 1(50%)-Progression to ESRD |